Integrated Diagnostics Holdings plc
IDGXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $5,719,742 | $4,122,506 | $3,605,047 | $5,224,712 |
| % Growth | 38.7% | 14.4% | -31% | – |
| Cost of Goods Sold | $3,538,189 | $2,598,159 | $2,142,984 | $2,420,647 |
| Gross Profit | $2,181,553 | $1,524,347 | $1,462,063 | $2,804,065 |
| % Margin | 38.1% | 37% | 40.6% | 53.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $324,057 | $256,066 | $201,721 | $198,878 |
| SG&A Expenses | $532,997 | $401,391 | $359,383 | $316,784 |
| Sales & Mktg Exp. | $208,940 | $145,325 | $157,662 | $117,906 |
| Other Operating Expenses | $434,208 | $385,194 | $270,489 | $225,221 |
| Operating Expenses | $967,205 | $786,585 | $629,872 | $542,005 |
| Operating Income | $1,214,348 | $737,762 | $832,191 | $2,262,060 |
| % Margin | 21.2% | 17.9% | 23.1% | 43.3% |
| Other Income/Exp. Net | $225,247 | -$406 | $21,456 | -$29,739 |
| Pre-Tax Income | $1,439,595 | $737,356 | $853,647 | $2,232,321 |
| Tax Expense | $431,221 | $268,993 | $327,064 | $739,815 |
| Net Income | $1,077,434 | $510,304 | $541,110 | $1,412,609 |
| % Margin | 18.8% | 12.4% | 15% | 27% |
| EPS | 1.82 | 0.85 | 0.9 | 2.35 |
| % Growth | 114.1% | -5.6% | -61.7% | – |
| EPS Diluted | 1.82 | 0.85 | 0.9 | 2.35 |
| Weighted Avg Shares Out | 593,622 | 600,000 | 600,000 | 600,000 |
| Weighted Avg Shares Out Dil | 593,622 | 600,000 | 600,000 | 600,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | $144,675 | $53,484 | $95,371 | $113,178 |
| Interest Expense | $170,574 | $141,688 | $122,677 | $98,003 |
| Depreciation & Amortization | $482,798 | $401,238 | $317,343 | $238,644 |
| EBITDA | $2,092,967 | $1,280,282 | $1,293,667 | $2,568,968 |
| % Margin | 36.6% | 31.1% | 35.9% | 49.2% |